Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.02, $0.09 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $22.1 million versus the consensus estimate of $22.63 million.

GUIDANCE:

Rockwell Medical sees FY2024 revenue of $84-88 million, versus the consensus of $98.01 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.